🔎 Trials Near Me

Inicio › Mieloma múltiple › Rhode Island

Ensayos clínicos de Mieloma múltiple en Rhode Island

6 estudios sobre Mieloma múltiple buscan participantes en Rhode Island.

Ciudades en Rhode Island

Texto oficial del estudio (inglés)

A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma

  • Rhode Island Hospital, Providence
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 25 sept 2026 · NCT05552222

MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)

  • Rodhe Island Hospital, Providence
  • The Miriam Hospital, Providence
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 24 ago 2026 · NCT06152575

Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial

  • Smilow Cancer Hospital Care Center - Westerly, Westerly
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 19 ago 2026 · NCT04566328

Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment

  • Smilow Cancer Hospital Care Center - Westerly, Westerly
ReclutandoFase 3
Todas las edades · Todos los sexos · Actualizado el 10 jun 2026 · NCT05561387

A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)

  • GSK Investigational Site, Providence
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 22 abr 2026 · NCT06679101

IDP-023 as a Single Agent and in Combination With Antibody Therapies in Patients With Advanced Hematologic Cancers

  • Rhode Island Hospital, Providence
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 3 jun 2025 · NCT06119685

De ClinicalTrials.gov, datos obtenidos el 30 sept 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.